Fresenius SE & Co. KGaA stock (DE0005785604): Dividend of €1.05 per share set for May 27

German healthcare company Fresenius announced a dividend payment of €1.05 per share with an ex-date of May 27, 2026, representing a 2.74% yield for shareholders.

Fresenius SE & Co. KGaA, the German healthcare services provider, has scheduled a dividend payment of €1.05 per share for May 27, 2026, according to dividend calendar data as of May 14, 2026. The dividend represents a 2.74% yield based on current market valuations, providing income-focused investors with a regular return on their holdings in the healthcare company.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Fresenius SE & Co. KGaA
• Sector/industry: Healthcare services, dialysis, hospital management, ambulatory care
• Headquarters/country: Germany
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Dialysis services, hospital operations, medical care products
• Home exchange/listing venue: Frankfurt Stock Exchange (FRE)
• Trading currency: EUR

Fresenius: core business model

Fresenius operates as a diversified healthcare company providing essential medical services and products across multiple segments. The company's primary focus includes dialysis treatment for patients with kidney disease, hospital management and operations, and ambulatory medical care services. With operations spanning Europe, North America, and Asia-Pacific regions, Fresenius serves millions of patients annually through its network of treatment centers and healthcare facilities. The company's business model relies on recurring revenue from chronic disease management, positioning it as a defensive healthcare investment for investors seeking stable cash flows.

Main revenue and product drivers for Fresenius

Dialysis services represent a significant revenue pillar for Fresenius, as the aging global population and rising prevalence of chronic kidney disease drive consistent demand. The company's hospital management division operates facilities across multiple countries, generating revenue from patient care, surgical procedures, and ancillary services. Ambulatory care services, including outpatient treatment centers, contribute additional revenue streams. These diversified revenue sources provide Fresenius with resilience against sector-specific downturns and create multiple touchpoints with healthcare systems worldwide.

Conclusion

Fresenius' dividend announcement reflects the company's commitment to returning capital to shareholders while maintaining its position as a stable healthcare services provider. The €1.05 per share payment scheduled for May 27 offers income-oriented investors a meaningful yield in a sector characterized by essential services and demographic tailwinds. US investors with exposure to European healthcare stocks or seeking diversification into defensive healthcare services may monitor Fresenius' dividend consistency and operational performance as key indicators of shareholder value creation.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.